Xponance, Inc. Novavax Inc Transaction History

Xponance, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$5.76 - $12.48 $7,038 - $15,250	1,222 Added 10.88%	12,458 $86,000
Q4 2022 Jan 23, 2023	BUY	$8.86 - $25.04 $99,550 - $281,349	11,236 New	11,236 $0
Q2 2022 Aug 02, 2022	BUY	$36.28 - $75.29 $18,974 - $39,376	523 Added 6.01%	9,218 $474,000
Q1 2022 Apr 20, 2022	BUY	$69.73 - $142.9 $6,624 - $13,575	95 Added 1.1%	8,695 $640,000
Q4 2021 Jan 31, 2022	BUY	$134.56 - $217.97 $32,025 - $51,876	238 Added 2.85%	8,600 $1.23 Million
Q3 2021 Nov 05, 2021	SELL	$177.8 - $270.58 $57,785 - $87,938	-325 Reduced 3.74%	8,362 $1.73 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $1.05 Million - $2.24 Million	8,687 New	8,687 $1.84 Million
Q3 2020 Oct 26, 2020	SELL	$79.44 - $178.51 $213,375 - $479,477	-2,686 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $37,227 - $224,576	2,686 New	2,686 $224,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.